Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]
Omori Y, Kanbayashi T, Imanishi A, et al. Neuropsychiatr Dis Treat. 2018;14:451–457.On page 451, the Result section in the abstract, 2nd sentence reads “There were significant differences in the ESS scores and MSL between decreased and normal CSF orexin groups in DM1 patients&...
Main Authors: | Omori Y, Kanbayashi T, Imanishi A, Tsutsui K, Sagawa Y, Kikuchi YS, Takeshima M, Yoshizawa K, Uemura S, Shimizu T |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-05-01
|
Series: | Neuropsychiatric Disease and Treatment |
Online Access: | https://www.dovepress.com/corrigendum-orexinhypocretin-levels-in-the-cerebrospinal-fluid-peer-reviewed-article-NDT |
Similar Items
-
Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness
by: Omori Y, et al.
Published: (2018-02-01) -
Analysis and modelling of excessive daytime sleepiness in narcolepsy cataplexy syndrome and myotonic dystrophy
by: Cresswell, Paul William
Published: (2007) -
Editorial: Hypocretins/Orexins
by: Miguel López, et al.
Published: (2020-06-01) -
Hypocretin (Orexin) Replacement Therapies
by: Erica Seigneur, et al.
Published: (2020-12-01) -
Cerebrospinal Fluid Hypocretin-1 (Orexin-A) Level Fluctuates with Season and Correlates with Day Length.
by: Kim Boddum, et al.
Published: (2016-01-01)